MiR-150-5p Alleviates Renal Tubule Epithelial Cell Fibrosis via the Inhibition of Epithelial-Mesenchymal Transition

Zhizhong Zhang1, Xinyu Zhang2, Xiangming Gao3

  • 1Department of Urology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.

Abstract

Insights

MicroRNA (miR)-150-5p suppresses kidney fibrosis by targeting ZEB1. This finding offers new therapeutic strategies for renal fibrosis by modulating miR-150-5p and ZEB1 interactions.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • MicroRNA (miR)-150-5p is implicated in renal fibrosis progression.
  • The precise mechanism of miR-150-5p in renal fibrosis remains unclear.

Purpose of the Study:

  • To elucidate the role and mechanism of miR-150-5p in transforming growth factor beta 1 (TGF-β1)-induced renal fibrosis and epithelial-mesenchymal transition (EMT).

Main Methods:

  • Utilized a mouse model of unilateral ureteral obstruction and an in vitro model using human kidney 2 (HK-2) cells stimulated with TGF-β1.
  • Assessed expression of miR-150-5p, zinc finger E-box binding homeobox 1 (ZEB1), and fibrosis/EMT markers via Western blot and qRT-PCR.
  • Confirmed the miR-150-5p and ZEB1 interaction using a dual-luciferase reporter assay.

Main Results:

  • Renal fibrosis models showed decreased miR-150-5p and increased ZEB1.
  • TGF-β1 treatment induced EMT markers (decreased E-cadherin, increased α-SMA and Col-I) in HK-2 cells.
  • miR-150-5p overexpression inhibited TGF-β1-induced fibrosis and EMT, acting via direct targeting of ZEB1. ZEB1 overexpression reversed these effects.

Conclusions:

  • MiR-150-5p exerts a protective effect against TGF-β1-induced renal fibrosis and EMT by directly targeting ZEB1 in HK-2 cells.
  • This study provides a mechanistic understanding that could inform therapeutic strategies for renal fibrosis.

Related Concept Videos